Conference
The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study
Authors
Agnelli G; George DJ; Fisher W; Kakkar AK; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Turpie AGG
Volume
29
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2011
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X